Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Goodwill & Intangibles (2016 - 2025)

Avanos Medical's Goodwill & Intangibles history spans 11 years, with the latest figure at $794.4 million for Q2 2024.

  • For Q2 2024, Goodwill & Intangibles rose 256.87% year-over-year to $794.4 million; the TTM value through Jun 2024 reached $794.4 million, up 256.87%, while the annual FY2023 figure was $1.0 billion, 2.4% up from the prior year.
  • Goodwill & Intangibles for Q2 2024 was $794.4 million at Avanos Medical, roughly flat from $794.9 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $1.0 billion in Q4 2023 and bottomed at $145.3 million in Q3 2021.
  • The 5-year median for Goodwill & Intangibles is $797.6 million (2020), against an average of $700.0 million.
  • The largest annual shift saw Goodwill & Intangibles tumbled 73.02% in 2023 before it soared 256.87% in 2024.
  • A 5-year view of Goodwill & Intangibles shows it stood at $960.2 million in 2020, then dropped by 22.67% to $742.5 million in 2021, then soared by 36.2% to $1.0 billion in 2022, then increased by 2.4% to $1.0 billion in 2023, then fell by 23.29% to $794.4 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Goodwill & Intangibles are $794.4 million (Q2 2024), $794.9 million (Q1 2024), and $1.0 billion (Q4 2023).